Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Tirzepatide (Spartina) in Obese Kidney Transplant Recipients: A Pilot Study on Weight Loss, Gastrointestinal Tolerability, and Graft Function

NCT07423247 is registered in ClinicalTrials.gov with Shahid Beheshti University of Medical Sciences as lead sponsor.

NCT NCT07423247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07423247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Tirzepatide (Spartina) in Obese Kidney Transplant Recipients: A Pilot Study on Weight Loss, Gastrointestinal Tolerability, and Graft Function
Lead sponsor
Shahid Beheshti University of Medical Sciences
Phase
Phase 4
Overall status
Recruiting
Start date
January 1, 2026
Completion date
September 30, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tirzepatide